Canada
It appeared Health Canada was increasing access to the substance, but recent events suggest otherwise
Hi, what are you looking for?
Mugglehead Investment Magazine
Psychedelics
Business
Stock will start trading at market open Thursday under the symbol NUMIF
Business
Expenses were down 71% but the firm still reported a $5.4-million loss
International
Two separate trials will look at MDMA for alcohol use and PTSD, as well as psilocybin-assisted therapy for anorexia nervosa
Business
If approved, it will mark the firm's first independent clinical trial with a proprietary extract
Canada
Following the trial's approval from Health Canada, psychedelic practitioners can now apply to be research subjects
Canada
The new rules will facilitate safer access to substances like psilocybin, but many in need won't qualify, experts say
Psychedelics
Currently treatments are largely insufficient, so care providers encourage more research despite stigma
Canada
Psychedelics firm Numinus says amendments made to the country's Special Access Programme come into effect in January
Business
The psychedelics firm has been aggressively expanding lab space while pushing ahead with clinical trials
